Interleukin-10 suppression of myeloid cell activation--a continuing puzzle. - Wikidata - wikimedia - TriplyDB

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

http://www.wikidata.org/entity/Q33340529

about

Interleukin-10: new perspectives on an old cytokine The Complex Role of STAT3 in Viral Infections Innate Immunity Fights Alzheimer's Disease Obesity induces a phenotypic switch in adipose tissue macrophage polarization Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin.The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription.Toll-like receptors expression in follicular cells of patients with poor ovarian response Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13.Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3.Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease Adenosine 5'-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.Brazilian Red Propolis Attenuates Inflammatory Signaling Cascade in LPS-Activated Macrophages.ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions Knockout of Mkp-1 exacerbates colitis in Il-10-deficient mice.The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation.Immunotherapy for the prevention and treatment of type 1 diabetes.Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.Fractionation and characterization of biologically-active polysaccharides from Artemisia tripartita.Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages.Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA.Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache.Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis.Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production.Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner.Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-alpha expression in macrophages by reducing IL-10 expression.Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10.Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells.Cytokine networks in glioma.Inflammatory bowel disease: is it a primary immunodeficiency?Role of interleukin-10 in breast cancer.Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice.

P2860

Q24653771-5B2FBECB-592F-4F49-B574-BF4E3B0CADB5 Q26801053-80CE36AB-EE8A-4A02-A097-95A27D967204 Q28081826-4F5F357D-5B8C-4E09-820D-F81F2AFFD009 Q29547686-F8ACC592-32F8-46BE-90C4-3A972A2FC0DC Q33849200-CA080255-D19D-444A-A613-6FCFDB044EF9 Q33853873-153B6415-499D-4674-86AD-1B155DBEE6C8 Q33937289-9F5ECA61-236B-41A4-8520-36CA88272504 Q34486748-821D6635-FF12-474C-AD05-534134BFFD5F Q34729528-699B1FCF-167D-4DED-9B20-2CCCCA219B09 Q35062006-D3AE7F99-E812-4955-8292-BAB9080D3B30 Q35067905-F60CB023-3FFA-44C7-A268-C83A3D4B88D3 Q35104872-A21DCC75-5F01-41D8-8FBE-8B146BEEC2BA Q35128571-C0B4E0C3-4AC6-4173-8002-859F04386117 Q35155067-6CB6DBDA-D992-4786-864F-FE01C34AEBBA Q35249558-349206FF-E831-4810-82D8-922D75CD8145 Q35558638-E38B427F-D0DD-4E2F-82B7-143FD569E357 Q35625089-542B40BA-50AF-4AB4-9D11-C76B6D57A5E8 Q35867602-EAF5125F-9C25-4ACF-90A7-FE7CABA0AAB8 Q35948145-22963F07-0833-4B75-B2F2-BF3C462FDE9D Q36042149-E8397AC3-278C-4B78-ABE5-1C5750968E83 Q36094314-E2FAEB05-24F2-4D8F-9F68-21D303346E6B Q36121600-097AC47E-33C8-4F56-A1D0-706910FF7BE7 Q36327355-7AB5E905-8F9A-48D8-9A24-01E06A991568 Q36543665-E3E26A0E-B511-4925-9BE9-6059BA328F16 Q36647941-2B8641B6-2022-46B0-B984-30746ACA8444 Q36737978-E74CF067-6B49-488E-A123-61DA8025C85A Q36738319-E250EDA9-3601-482E-ADE1-F6371B039D55 Q36843317-1BC0EBF9-79BB-4BCA-A9AB-595C83D6F482 Q36869485-8B6075FF-10D9-4912-A224-7E8BB50DDEA1 Q36944764-81770B4D-47AE-4C43-97EA-FB74F0989285 Q36993214-C14199F4-B006-48FF-B1F0-4B0E0E8E2029 Q37191048-889CD86A-796F-4E72-B74F-391200352378 Q37233985-2F7A473A-34FB-475F-A297-F3730E975AF5 Q37236661-2E2580CB-8464-4F64-9F1B-00B7D19B5CFC Q37371476-4C8FAAC0-3612-4457-A48A-1C5DE1EAF0DF Q37416567-6085289B-D9B5-446D-B13A-F59E6B7E2CE9 Q37886819-BDF192BE-B420-45CB-8259-C0AD46FE3958 Q37945495-BAA04E78-3CB8-4E8F-85C0-5324B00B4BDB Q37953317-B6920A5E-E848-4697-B757-FC4BECC37A34 Q37963808-857C6ADD-2832-47D8-A3C7-92FE26D08308

P2860

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

http://www.wikidata.org/entity/Q33340529

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

@ast

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

@en

type

label

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

@ast

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

@en

prefLabel

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

@ast

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

@en

P1433

Q33340529-DAE62519-E520-4CAB-AB17-3E4519863FB7

P1476

Q33340529-0D6E31A4-089D-4F30-B5F1-E4FA2F9F4294

P2093

Q33340529-167CEBBE-D5F1-4201-8D11-86B22C3A7284

Q33340529-1850ACFA-F38E-4A0C-B5F0-90ABC5D92E2C

Q33340529-2BF3BB57-2EC3-4981-BF6D-A8951C726179

Q33340529-50694ED5-B3AA-442B-AA4D-A688A0CDA9E5

Q33340529-E87AC37F-27D0-41DB-B320-7EDEF4257827

P2860

Q33340529-0544522A-262C-4952-AFBC-BEAB1C79B6CE

Q33340529-078B6F0C-DBA7-4954-A5D9-41D9981AB1D7

Q33340529-09013BF0-07E7-497A-A074-268479AD2D2F

Q33340529-0B2EF90E-CEC9-46F2-A913-61F278A53752

Q33340529-0D9C0757-B8FD-4BFF-A420-D88107FC4801

Q33340529-0F63A15B-5A1E-4817-855D-44CD82249C15

Q33340529-1237D87B-8CA4-40E8-950A-949C9A44D028

Q33340529-126291FE-D183-4F38-8E4A-3401FD4A5681

Q33340529-131DB4B8-FD45-4220-897B-38DA4C1E20C6

Q33340529-132B6F25-61C3-4AF3-AFB3-CAE1EB08B5A7

P304

Q33340529-A7BD6557-E7B4-4E85-A2EF-4736EF591BD7

P31

Q33340529-BE3C6169-19CC-44CB-B04F-87F3B51363AA

P356

Q33340529-4C410DF1-417E-4452-8271-2E2D177EA790

P433

Q33340529-09FE8956-DBFE-4BE7-A41E-FEE8732877B3

P478

Q33340529-A4A313D9-2980-47FE-9A35-5A2647EFF9DC

P577

Q33340529-869712A2-5FCC-43A8-B3F2-EA940E0CDF61

P5875

Q33340529-016642EE-B627-4685-A9E4-0075EC931F3C

P698

Q33340529-2E163D85-DD81-447F-BEEE-BB52B2FC881E

P921

Q33340529-4b6c03be-6a3d-4cfd-8cf3-155c09fcce8a

P932

Q33340529-9319EE64-F49A-4FC5-918F-868DA8C3CF7B

P356

J.1365-2567.2004.01988.X

P1433

P1476

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

@en

P2093

Brian M J Foxwell

http://www.w3.org/2001/XMLSchema#string

Giuseppe Ricchetti

http://www.w3.org/2001/XMLSchema#string

Lynn M Williams

http://www.w3.org/2001/XMLSchema#string

Timothy Smallie

http://www.w3.org/2001/XMLSchema#string

Usha Sarma

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri

Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R

Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor

Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)

Interleukin-10 and the interleukin-10 receptor

Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22

Human interleukin-10 can directly inhibit T-cell growth

The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

The NF-kappa B and I kappa B proteins: new discoveries and insights

P304

281-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2567.2004.01988.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8215704

http://www.w3.org/2001/XMLSchema#string

P698

15500614

http://www.w3.org/2001/XMLSchema#string

P921

P932

1782589

http://www.w3.org/2001/XMLSchema#string